Medicamen Biotech Ltd Share Price

Q: What is the share price of Medicamen Biotech Ltd today?

Medicamen Biotech Ltd share price as on 12 Jun 2026 is ₹226.15

Pharmaceuticals

NSE: MEDICAMEQ Small Cap ISIN: INE646B01010

As on 13 June 2026 at 01:12 IST

₹226.15

+ 2.25

(1.00%)

Sell Buy

Over 1 Month

-23.22%

Over 6 Months

-42.73%

Over 1 Year

-47.32%

Over 3 Years

-66.21%

Medicamen Biotech Ltd Summary

Close ₹223.90

Open ₹230

High ₹231

Low ₹219

Volume 15,159

Net Turnover (in Cr) ₹0.34

52Wk High ₹447.65

52Wk Low ₹216.95

52Wk High / Low

216.95

447.65

Medicamen Biotech Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹303.67

EPS (TTM) 6.94

Book Value (BV) 206.25

Div. Yield 0.44 %

P/E (TTM) 32.52

Price/Book Value 1.09

Delivery % 65.82 %

Face Value 10

Key Ratios

PE Ratio 64.83

PB Ratio 2.81

EV to Sales 4.20

PEG Ratio -2.24

ROA 3.82

ROE 4.43

Debt-Equity 0.13

Net Profit Margin 6.24

Operating Profit Margin 15.41

Medicamen Biotech Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	168.79	181.63	143.33	117.17	113.47
Total Expenses	158.91	168.56	126.28	99.07	97.08
Profit Before Tax	9.88	13.08	17.05	18.09	16.39
Profit After Tax	6.56	9.49	14.73	14.90	12.13
Operating Profit After Depreciation	13.04	17.47	19.97	19.50	17.46

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	87.10	91.85	92.66	92.48	89.64
Total Non Current Assets	132.60	134.96	115.15	102.66	97.69
Total Current Assets	164.55	159.59	163.36	123.04	96.03
Total Assets	297.15	294.55	278.52	225.69	193.72
Total Shareholder's Fund	213.05	206.98	193.41	146.47	132.89

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-8.16	-6.74	-6.29	4.11	12.77
Net Cash Used In Investing Activities	-1.40	-5.56	-5.88	-8.47	-17.81
Net Cash Used In Financing Activities	-1.47	6.31	29.13	4.30	5.84

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	157.69	174.69	140.35	117.17	110.90
Total Expenses	144.91	157.80	123.01	99.06	94.15
Profit Before Tax	12.77	16.89	17.33	18.10	16.75
Profit After Tax	9.45	13.30	15	14.91	12.49
Operating Profit After Depreciation	15.82	21.27	20.26	19.50	17.82

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	86.31	91.10	92.36	92.48	89.64
Total Non Current Assets	139.68	141.84	118.81	104.72	99.75
Total Current Assets	153.51	152.37	157.97	120.98	92.43
Total Assets	293.19	294.21	276.78	225.70	192.18
Total Shareholder's Fund	217.64	209.21	193.80	148.04	134.35

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-2.63	-0.25	-3.50	4.81	12.98
Net Cash Used In Investing Activities	-1.72	-8.71	-7.54	-8.47	-17.81
Net Cash Used In Financing Activities	-6.68	3.14	27.67	4.39	5.68

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	60.65	46.91	47.17	43.04	29.61
Total Expenses	55.21	42.53	42.01	38.43	31.22
Profit Before Tax	5.07	2.11	2.68	2.13	2.49
Profit After Tax	4.45	1.63	2.11	1.60	1.86
Operating Profit after Depreciation	7.18	4.91	5.53	5.08	3.62

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	54.68	43.49	42.23	38.45	26
Total Expenses	50.55	38.41	37.18	34.42	27.09
Profit Before Tax	3.53	3.08	2.77	2.17	3.04
Profit After Tax	2.97	2.59	2.21	1.64	2.41
Operating Profit after Depreciation	5.86	5.61	5.42	4.50	4.13

Medicamen Biotech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 218.27

S2 212.63

S3 206.27

Pivot 224.63

R1 230.27

R2 236.63

R3 242.27

Moving Average

20 SMA 261.22

50 SMA 257.98

100 SMA 289.24

200 SMA 325.96

Medicamen Biotech Ltd Corporate Actions

Medicamen Biotech Ltd

₹1.0/Share

Announcement Date 19 Sep 2025

Record Date 19 Sep 2025

Div Yield 10%

AGM Date: 25 Sep 2021

Medicamen Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 19 2021 to September 25 2021 (both days inclusive) for the purpose of Payment of Dividend & 28th Annual General Meeting (AGM) of the Company to be held on September 25 2021. The Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2021. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on June 30, 2021 as Annexure-A and b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B This is for your information and records. (As per BSE Announcement Dated on 13/8/2021) Pursuant to Regulation 44(3) of Listing Regulations and our letter dated September 25 2021 Please find enclosed herewith: 1. Voting results of the 28th AGM held on Saturday September 25 2021 ISKCON Auditorium Hare Krishna Hill Sant Nagar Main Road East of Kailash New Delhi-110065 (Annexure 1); and 2. Consolidated Scrutinizers Report pursuant to Section 108 of the Companies Act 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014 (Annexure 2). A copy of the above is being uploaded on website of the Company www.medicamen.com and Link In Time India Private Limited (LIIPL). (As Per BSE Announcement Dated on 9/25/2021 6:26:33 AM) Pursuant to Regulation 44(3) of Listing Regulations and our letter dated September 25 2021 Please find enclosed herewith: 1. Voting results of the 28th AGM held on Saturday September 25 2021 ISKCON Auditorium Hare Krishna Hill Sant Nagar Main Road East of Kailash New Delhi-110065 (Annexure 1); and 2. Consolidated Scrutinizers Report pursuant to Section 108 of the Companies Act 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014 (Annexure 2). A copy of the above is being uploaded on website of the Company www.medicamen.com and Link In Time India Private Limited (LIIPL). (As Per BSE Announcement Dated on 9/29/2021 5:59:43 AM)

AGM Date: 27 Sep 2022

This is to inform that the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today i.e. August 10, 2022. Further details attached. Pursuant to Regulation 30 and 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 29th Annual General Meeting ('AGM') of the Company scheduled to be held on Tuesday, the 27th day of September, 2022 at 11.00 a.m. (IST) at ISKCON Auditorium, Hare Krishna Hill, Sant Nagar Main Road, East of Kailash, New Delhi-110065, along with the Annual Report of the Company for the Financial Year 2021-2022. The Notice of the AGM and the Annual Report has also been uploaded on the website of the Company at www.medicamen.com . This is for your information and records. (As per BSE Announcement Dated on 3/9/2022) OUTCOME/ SUMMARY OF PROCEEDINGS OF THE 29TH ANNUAL GENERAL MEETING OF MEDICAMEN BIOTECH LIMITED HELD ON 27/09/2022 (As Per BSE Announcement dated on 27.09.2022) Voting Results of 29th Annual General Meeting ('AGM') of Medicamen Biotech Limited held on September 27, 2022 (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 27 Sep 2023

Outcome of the Board Meeting held on August 08, 2023 Outcome/Summary of proceedings of the 30th Annual General Meeting of Medicamen Biotech Limited held on 27.09.2023. (As per BSE Announcement Dated on 27/09/2023)

AGM Date: 26 Sep 2024

AGM 26/09/2024 Book Closure Intimation (As per BSE Announcement Dated on 02/09/2024) We hereby submit the summary of the proceedings of the 31st Annual General Meeting of the Company held on Thursday, September 26, 2024 through Video Conferencing / Other Audio Visual means which commenced at 12.00 PM (IST) and concluded at 01.00 PM (IST). (As Per Bse Announcement Dated on 26.09.2024)

AGM Date: 26 Sep 2025

Outcome of the Board meeting held on August 12, 2025 Outcome of the 32nd Annual General Meeting of the Company. (As Per Bse Announcement dated on 26/09/2025) Voting Results of the 32nd AGM along with the consolidated Scrutinizer Report. (As per BSE Announcement dated on: 27/09/2025)

EGM Date: 26 Aug 2022

EGM 26/08/2022 Outcome of Board Meeting held on 01.08.2022 (As Per BSE Announcement Dated on 01.08.2022) In terms of Regulation 30 of Securities and Exchange Board of India ('SEBI') (Listing Obligations and Disclosure Requirement) Regulations, 2015, and other applicable provisions of Listing Regulations, please find enclosed herewith the Notice convening Extraordinary General Meeting ('EGM') of the Company. The Extraordinary General Meeting of the Members of the Company will be held on Friday, August 26, 2022 at 11.00 AM through Video Conferencing (VC) or Other Audio Visual Means (OAVM) in accordance with the aforesaid circulars. (As Per BSE Announcement Dated on 02.08.2022) Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclose herewith newspaper advertisement cutting for Extra- Ordinary General Meeting along with record dates and details of e-voting information, published in 'The Financial Express and Jansatta'' on 03.08.2022. (As Per BSE Announcement dated on 03.08.2022) In continuation to our intimation dated August 01, 2022, we are submitting herewith the Corrigendum to the notice of Extra Ordinary General Meeting ('EGM') scheduled to be held on Friday, August 26, 2022 at 11:00 a.m. through Video Conferencing / Other Audio-Visual Means. A Corrigendum has been issued to inform the Shareholders of the Company the changes in the explanatory statement as set out for the Item No. 1 and 2, contained in the EGM Notice. Same is enclosed herewith. All other particulars and details as mentioned in the EGM Notice shall remain unchanged. The corrigendum shall be read in conjunction with the EGM Notice dated August 01, 2022 together with explanatory statement. This corrigendum is also available on the Company's website viz. www.medicamen.com. You are requested to take the same on your record. (As Per BSE Announcement Dated on 18.08.2022) The Extraordinary General Meeting ('EGM') of Shareholders of the Company was held on Friday, August 26, 2022, at 11:00 AM and concluded at 11:45 AM through video conferencing/other audio visual means in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India in this regard and business(es) mentioned in the Notice dated August 01, 2022, convening the EGM, transacted thereat. In the EGM, the item of business mentioned in the notice was duly considered and discussed. However, the consolidated results of voting at the EGM and remote E-voting opted by the Shareholders will be provided separately, once the report from the scrutinizer will be received. In this regard, please find enclosed herewith, the proceedings of EGM for your information and records. (As Per BSE Announcement Dated on 26.08.2022) In terms of Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (the 'Regulation'), we are furnishing the details of the Remote e-voting and E-voting results at the Extraordinary General Meeting (EGM) of the Company held on August 26, 2022 in the prescribed format. (As Per BSE Announcement Dated on 27.08.2022) Medicamen Biotech Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 05.09.2022)

EGM Date: 26 Mar 2025

Announcement under Regulation 30 (LODR)- Issue of Securities Approved the draft notice of Extra-Ordinary General Meeting to be held on Wednesday, March 26,2025 at 12:00 Noon (IST) through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) facility, to seek approval of members of the Company Notice of Extra Ordinary General Meeting - Wednesday, March 26, 2025 (As per BSE Announcement Dated on 03/03/2025) A corrigendum has been issued to inform the Shareholders of the Company, of the changes in explanatory statement as set out for Item No 1 & 2, contained in the EGM notice. The same is enclosed herewith. (As Per BSE Announcement Dated on: 20/03/2025) Proceedings of Extra Ordinary General Meeting of the Shareholders of the Company held on Wednesday, March 26, 2025 at 12:00 PM and concluded at 12:45 PM (As per BSE Announcement Dated on 26/03/2025) Scrutinizer''s Report and Voting Result under Regulation 44 of the SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement Dated on 28/03/2025)

Medicamen Biotech Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Medicamen Biotech Ltd Top Mutal Funds Invested

No data available

Medicamen Biotech Ltd News

Board of Medicamen Biotech recommends final dividend

Of Rs 1 per share

28 May 2026, 03:39 pm

Medicamen Biotech to announce Quarterly Result

On 27 May 2026

22 May 2026, 11:34 am

Medicamen Biotech to convene board meeting

On 13 February 2026

05 Feb 2026, 12:29 pm

Medicamen Biotech to table results

On 14 November 2025

06 Nov 2025, 04:16 pm

Medicamen Biotech AGM scheduled

On 26 September 2025

20 Aug 2025, 12:47 pm

Medicamen Biotech Ltd Stock Analysis

Annual revenue for Medicamen Biotech Ltd decreased by 9.73% to ₹157.69 crore in FY 2025 from ₹174.69 crore in FY 2024.
Annual Net Profit for Medicamen Biotech Ltd decreased by 28.96% to ₹9.45 crore in FY 2025 from ₹13.30 crore in FY 2024.
Promoter Shareholding in Medicamen Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 40.46% in December 2025 to 40.46% in March 2026.
Medicamen Biotech Ltd delivered a 1-year return of -47.32% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Medicamen Biotech Ltd share price moved up by 1.00% from its previous close of INR ₹223.90. The latest Medicamen Biotech Ltd share price is INR ₹226.15.
Medicamen Biotech Ltd share price today has been at a low of 224.35 and a high of 227.80. Over the past 52 weeks, the Medicamen Biotech Ltd share price has seen a low of 216.95 and a high of 447.65.